HOME >> BIOLOGY >> NEWS
American Society for Microbiology to host 46th ICAAC September 27-30 in San Francisco

Press registration materials are now available online for the American Society for Microbiology's 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) being held September 27-30, 2006 in San Francisco, CA.

Known as the preeminent world meeting for presenting new information on clinical and basic research in infectious diseases and anti-infective therapy, ICAAC has also traditionally served as a forum for the introduction of new antimicrobial agents. This year's ICAAC will attract approximately 9,500 attendees from the United States and abroad and over 130 exhibitors are expected to display the latest in research, equipment, products and publications in the field.

Members of the media are invited to attend and comprehensive media facilities will be available. All media representatives must be registered to attend sessions; registration is limited to a maximum of three individuals from a single media outlet. Please note that videotaping in session rooms, the exhibit hall and post sessions is not allowed.

Journalists interested in attending can find registration materials online at http://www.asm.org/Media/index.asp?bid=43424. The pre-
registration/housing deadline is August 25, 2006. As the ICAAC housing block often sells out quickly and far in advance of the housing deadline, journalists are strongly encouraged to pre-register as early as possible.

The press room will be open for registration from 12 noon to 5 p.m. on Tuesday, September 26 and sessions begin on Wednesday morning. An opening press briefing has been tentatively scheduled for 12 noon on Wednesday, September 27.


'"/>

Contact: Carrie Patterson
cpatterson@asmusa.org
202-942-9389
American Society for Microbiology
29-Jun-2006


Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. American Chemical Society meets Aug. 19-23 in Boston
4. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
5. American buffalo slaughter fueled by international trade
6. American Chemical Societys Weekly PressPac -- July 25, 2007
7. American Chemical Societys Weekly PressPac -- July 18, 2007
8. American Chemical Societys Weekly PressPac -- July 11, 2007
9. Tips from the Journals of the American Society for Microbiology
10. Wiley extends publishing partnership with the American Institute of Chemical Engineers
11. Highlights from the July 2007 Journal of the American Dietetic Association

Post Your Comments:
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... 2015 Research and ... the "Natural Language Processing Market by Type ... Pattern & Image Recognition) - Worldwide Forecast to ... The key vendors occupying the market are 3M, ... Corporation, NetBase Solutions, SAS Institute Inc., Verint Systems ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/30/2015)... ... , ... Ralco is honored to announce that it is the primary sponsor ... August 5-9 in Marshall. The Ralco Enrichment Center is an interactive experience where the ... their daily lives. This unique exhibit also features a birthing center for fair goers ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: